428 related articles for article (PubMed ID: 28745578)
1. Cost-effectiveness of G5 Mobile continuous glucose monitoring device compared to self-monitoring of blood glucose alone for people with type 1 diabetes from the Canadian societal perspective.
Chaugule S; Graham C
J Med Econ; 2017 Nov; 20(11):1128-1135. PubMed ID: 28745578
[TBL] [Abstract][Full Text] [Related]
2. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial.
Wan W; Skandari MR; Minc A; Nathan AG; Winn A; Zarei P; O'Grady M; Huang ES
Diabetes Care; 2018 Jun; 41(6):1227-1234. PubMed ID: 29650803
[TBL] [Abstract][Full Text] [Related]
4. Continuous glucose monitoring systems for type 1 diabetes mellitus.
Langendam M; Luijf YM; Hooft L; Devries JH; Mudde AH; Scholten RJ
Cochrane Database Syst Rev; 2012 Jan; 1(1):CD008101. PubMed ID: 22258980
[TBL] [Abstract][Full Text] [Related]
5. Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France.
Alshannaq H; Pollock RF; Joubert M; Ahmed W; Norman GJ; Lynch PM; Roze S
J Comp Eff Res; 2024 Mar; 13(3):e230174. PubMed ID: 38294332
[No Abstract] [Full Text] [Related]
6. Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial.
Ruedy KJ; Parkin CG; Riddlesworth TD; Graham C;
J Diabetes Sci Technol; 2017 Nov; 11(6):1138-1146. PubMed ID: 28449590
[TBL] [Abstract][Full Text] [Related]
7. Long-term Cost-Effectiveness of Dexcom G6 Real-time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Patients With Type 1 Diabetes in the U.K.
Roze S; Isitt J; Smith-Palmer J; Javanbakht M; Lynch P
Diabetes Care; 2020 Oct; 43(10):2411-2417. PubMed ID: 32647050
[TBL] [Abstract][Full Text] [Related]
8. Long-term cost-effectiveness of Dexcom G6 real-time continuous glucose monitoring system in people with type 1 diabetes in Australia.
Isitt JJ; Roze S; Tilden D; Arora N; Palmer AJ; Jones T; Rentoul D; Lynch P
Diabet Med; 2022 Jul; 39(7):e14831. PubMed ID: 35298036
[TBL] [Abstract][Full Text] [Related]
9. Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose and intermittently scanned continuous glucose monitoring in people with type 1 diabetes receiving multiple daily insulin injections in Denmark.
Alshannaq H; Cogswell G; Pollock RF; Ahmed W; Norman GJ; Lynch PM; Roze S
Diabetes Obes Metab; 2023 Sep; 25(9):2704-2713. PubMed ID: 37334522
[TBL] [Abstract][Full Text] [Related]
10. Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada.
Alshannaq H; Isitt JJ; Pollock RF; Norman GJ; Cogswell G; Lynch PM; Roze S
J Comp Eff Res; 2023 Oct; 12(10):e230075. PubMed ID: 37668608
[No Abstract] [Full Text] [Related]
11. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial.
Wan W; Skandari MR; Minc A; Nathan AG; Zarei P; Winn AN; O'Grady M; Huang ES
Med Decis Making; 2018 Nov; 38(8):942-953. PubMed ID: 30403576
[TBL] [Abstract][Full Text] [Related]
12. Population-Level Impact and Cost-effectiveness of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring Technologies for Adults With Type 1 Diabetes in Canada: A Modeling Study.
Rotondi MA; Wong O; Riddell M; Perkins B
Diabetes Care; 2022 Sep; 45(9):2012-2019. PubMed ID: 35834175
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of real-time continuous monitoring glucose compared to self-monitoring of blood glucose for diabetes mellitus in Spain.
García-Lorenzo B; Rivero-Santana A; Vallejo-Torres L; Castilla-Rodríguez I; García-Pérez S; García-Pérez L; Perestelo-Pérez L
J Eval Clin Pract; 2018 Aug; 24(4):772-781. PubMed ID: 29971893
[TBL] [Abstract][Full Text] [Related]
14. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Long-Term Cost-Effectiveness of the Dexcom G6 Continuous Glucose Monitor versus Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in Canada.
Roze S; Isitt JJ; Smith-Palmer J; Lynch P
Clinicoecon Outcomes Res; 2021; 13():717-725. PubMed ID: 34408456
[TBL] [Abstract][Full Text] [Related]
16. A European Cost-Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes.
Jendle J; Buompensiere MI; Ozdemir Saltik AZ; de Portu S; Smith-Palmer J; Pollock RF; Cohen O
Diabetes Technol Ther; 2023 Dec; 25(12):864-876. PubMed ID: 37801658
[No Abstract] [Full Text] [Related]
17. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Hybrid Closed Loop Insulin Pumps Versus Multiple Daily Injections Plus Intermittently Scanned Glucose Monitoring in People With Type 1 Diabetes in The Netherlands.
Serné EH; Roze S; Buompensiere MI; Valentine WJ; De Portu S; de Valk HW
Adv Ther; 2022 Apr; 39(4):1844-1856. PubMed ID: 35226346
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
Nicolucci A; Rossi MC; D'Ostilio D; Delbaere A; de Portu S; Roze S
Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):707-715. PubMed ID: 29753586
[TBL] [Abstract][Full Text] [Related]
20. Combined continuous glucose monitoring and subcutaneous insulin infusion versus self-monitoring of blood glucose with optimized multiple injections in people with type 1 diabetes: A randomized crossover trial.
Dicembrini I; Pala L; Caliri M; Minardi S; Cosentino C; Monami M; Mannucci E
Diabetes Obes Metab; 2020 Aug; 22(8):1286-1291. PubMed ID: 32166907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]